Catalogo Articoli (Spogli Riviste)
OPAC HELP
Titolo: Outcome in schizophrenia: Beyond symptom reduction
Autore: Meltzer, HY;
- Indirizzi:
- Vanderbilt Univ, Sch Med, Dept Psychopharmacol, Nashville, TN 37212 USA Vanderbilt Univ Nashville TN USA 37212 pharmacol, Nashville, TN 37212 USA
- Titolo Testata:
- JOURNAL OF CLINICAL PSYCHIATRY
,
volume: 60,
anno: 1999,
supplemento:, 3
pagine: 3 - 8
- SICI:
- 0160-6689(1999)60:<3:OISBSR>2.0.ZU;2-F
- Fonte:
- ISI
- Lingua:
- ENG
- Soggetto:
- NEUROLEPTIC-RESISTANT SCHIZOPHRENIA; QUALITY-OF-LIFE; ANTIPSYCHOTIC AGENTS; COST-EFFECTIVENESS; RISPERIDONE; CLOZAPINE;
- Tipo documento:
- Article
- Natura:
- Periodico
- Settore Disciplinare:
- Social & Behavioral Sciences
- Clinical Medicine
- Citazioni:
- 24
- Recensione:
- Indirizzi per estratti:
- Indirizzo: Meltzer, HY VanderbiltNashville, Med, Dept Psychopharmacol, 1601 23rd Ave S,Suite 306, Vanderbilt Univ 1601 23rd Ave S,Suite 306 Nashville TN USA 37212
-
-
-
- Citazione:
- H.Y. Meltzer, "Outcome in schizophrenia: Beyond symptom reduction", J CLIN PSY, 60, 1999, pp. 3-8
Abstract
Although some patients with schizophrenia may have a single episode and recover, the vast majority remain iii and unable to work for life. In the United States, patients with schizophrenia use 2.5% of the annual total healthcare allocations. The atypical antipsychotics, particularly when combined with psychosocial treatment, hold the promise of improving outcome and reducing the economic burden on society. Both clinical outcome and cost effectiveness are best evaluated in the context of a comprehensive assessment of arange of meaningful outcome measures studied in clinical situations. Evidence exists that the atypical antipsychotics not only reduce positive and negative symptoms and cause fewer side effects than conventional neuroleptics, but also lessen cognitive impairment, lead to a better quality of life, and have antidepressant effects, all of which should result in improved outcome in patients with schizophrenia. Increasing the availability of the atypical agents should be cost effective for society by restoring productivity in some patients with schizophrenia.
ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 19:00:28